Valuation: Shivalik Rasayan Limited

Market Cap 3.49B 36.59M 31.81M 29.6M 27.18M 51.33M 52.12M 349M 137M 1.74B 137M 134M 5.83B P/E 2024
69.1x
P/E 2025 59.1x
Enterprise Value 4.26B 44.63M 38.8M 36.11M 33.15M 62.61M 63.58M 426M 167M 2.12B 168M 164M 7.11B EV / Sales 2024
3.49x
EV / Sales 2025 3.4x
Free-Float
41.43%
Yield 2024
0.09%
Yield 2025 0.08%
07-24 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
05-27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
05-27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26 CI
05-27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
02-13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/09/25 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/08/25 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
30/05/25 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
24/04/25 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
26/02/25 Medicamen Biotech Limited announced that it expects to receive INR 775.7875 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD CI
1 day+4.45%
1 week-1.49%
Current month+4.45%
1 month+12.42%
3 months-2.71%
6 months-14.14%
Current year-27.50%
1 week 246.1
Extreme 246.1
271.4
1 month 211.45
Extreme 211.45
271.4
Current year 206
Extreme 206
371.3
1 year 206
Extreme 206
634
3 years 206
Extreme 206
890.05
5 years 206
Extreme 206
1,196.8
10 years 53.24
Extreme 53.24
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 17/11/2018
Director of Finance/CFO - 01/11/2001
Chief Tech/Sci/R&D Officer - 11/01/2024
Director TitleAgeSince
Chairman 62 23/02/2002
Director/Board Member 67 18/07/2003
Director/Board Member - 13/11/2018
Date Insider Type Main position Quantity % Market Cap.
1/7/24 Don 21,500 0.1382%
26/6/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+4.45%-1.49%-55.24%-68.66% 40.75M
-11.90%-11.81%+10.59%+40.81% 52.51B
+0.11%-.--%-.--%-.--% 12.96B
-0.34%-3.26%+27.60%+164.60% 10.48B
-1.65%+3.72%+23.33%+63.49% 8.06B
-2.32%-4.17%-17.86%-20.69% 6.53B
+2.16%+3.11%-9.75%+78.76% 5.6B
+2.59%+2.10%-12.78%+3.38% 5.34B
+5.45%+8.34%+32.62%+42.76% 5.11B
+2.54%+2.82%-31.79%-23.39% 4.37B
Average +0.14%-0.48%-3.33%+28.11% 11.1B
Weighted average by Cap. -5.31%-4.98%+7.38%+43.39%

Financials

2024 2025
Net sales 2.72B 28.45M 24.73M 23.02M 21.13M 39.91M 40.52M 271M 106M 1.35B 107M 104M 4.53B 3.1B 32.43M 28.19M 26.24M 24.09M 45.49M 46.2M 309M 121M 1.54B 122M 119M 5.17B
Net income 127M 1.33M 1.16M 1.08M 990K 1.87M 1.9M 12.71M 4.99M 63.31M 5M 4.89M 212M 167M 1.75M 1.52M 1.42M 1.3M 2.45M 2.49M 16.68M 6.55M 83.12M 6.57M 6.42M 279M
Net Debt 482M 5.05M 4.39M 4.09M 3.75M 7.09M 7.2M 48.19M 18.91M 240M 18.97M 18.56M 805M 768M 8.04M 6.99M 6.51M 5.97M 11.28M 11.45M 76.69M 30.1M 382M 30.2M 29.53M 1.28B
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
275
Date Price Change Volume
03/08/26 258.00 +4.45% 3,326
31/07/26 ₹247.00 -5.00% 2,116
30/07/26 ₹260.00 +1.76% 1,002
29/07/26 ₹255.50 -1.73% 1,500
28/07/26 ₹260.00 -0.73% 3,500
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock